Pfizer Partner of Choice (PoC) service collaborations expand the way Pfizer works together with biopharmaceutical partners (Partners) to advance innovative therapies. PoC offers unique differentiated capabilities with global scale and capacity, industry leading speed and quality to quickly develop quality assets, and one-stop shop with expertise across the entire development lifecycle.
The PoC organization will report into the Chief Business Innovation Office. The head of portfolio management will report to the head of the Partner of Choice (PoC) organization. The person will be responsible for assessing the innovation landscape within Pfizer’s focus areas and prioritizing top mechanisms, approaches, and modalities for Pfizer to focus on for partner of choice. Additionally, they will be responsible to assessing and tiering top target companies within the priority innovation areas for the account management team to focus on.
The head of portfolio management will also be responsible for optimizing the mix of the partner of choice portfolio, maintaining productivity (success rates and cycle times) and ensuring that the target number of programs are internalized. They will lead efforts to maximizing value of the partner of choice portfolio. The head of portfolio management will partner closely with chief scientific officers (CSOs) and chief development officers (CDOs) across Pfizer’s 6 therapeutic areas as well as the business development organization, the early science and innovation (ES&I) organization and the commercial development organization.
- Assess the innovation landscape within Pfizer’s focus areas established by Commercial Strategy and Innovation and identify top areas of innovationto prioritize for partner of choice including innovative modalities,mechanisms,and approaches
- Develop framework and criteria to prioritize potential target companies
- Within priority innovation areas use framework to tier target companies
- Guide potential deal structure(s) for each tier of priorities
- Work closely with Pfizer CSOs, CDOs as well as BD, ES&I and commercial development teams to inform priority areas and target companies
- Evolve priority innovation areas and target companies as needed and based on deals executed and evolving innovation priorities
- Assess the innovation landscape Outline guiding principles to inform mix for partner of choice portfolio
- Ensure that executed deals align well with priority areas and desired portfolio mix
- Develop ambitious R&D productivity metrics for the partner of choice portfolio and identify leading indicators of success
- Closely monitor the programs from the PoC portfolio that are internalized and ensure high quality and optimal scale and mix
- Support development of semester 2 goals for PoC LT and embed goals with key collaborators
- Guide activities of approximately 3 direct reports including directors and senior directors
- 20 + years of pharmaceutical industry and senior leadership experience
- PhD or MD in discipline related to biological sciences
- 5+ years in R&D strategy and/or portfolio management
- Strong understanding of emerging trends in science and the biopharmaceutical industry
- Outstanding communication and interpersonal skills; demonstrated result-orientation, tenacity, and follow-through
- The ability to be successful in a matrixed environment with a high degree of flexibility; collaborate well with Pfizer CSOs, CDOs as well as BD, ES&I and commercial development functions to accomplish business objectives
- Must have a proven track record of being effective at self-management and driving results
- Strong Financial and business acumen
- 10+ years in management consulting
NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS
- Office-based position with some business travel from time-to-time, including attending conferences
Additional Posting Information
- Last date to apply: September 3, 2022
Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
Research and Development